Studying How Sexual Activity Affects Low Blood Sugar Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin and Continuous Glucose Monitoring

What this Trial Is About

This research aims to understand if sexual activity affects the risk of low blood sugar hypoglycemia in adults with type 1 or type 2 diabetes who use insulin therapy and continuous glucose monitoring CGM. Sexual health is important but often overlooked in diabetes care, and fear of hypoglycemia during or after sexual activity may reduce quality of life. The study addresses this gap using new remote monitoring technology to study glucose changes related to sexual activity. Participants will use CGM systems like LibreView or Dexcom Clarity to track glucose levels during and up to 6 hours after sexual activity, which they mark in their CGM app using a neutral symbol. The study is observational with no assigned treatments participants continue their usual insulin therapy and self-management. Each person will be observed for 3 months, comparing glucose data from sexual activity days to days without sexual activity. During the study, researchers will collect glucose data remotely and receive basic clinical information from healthcare providers. They will analyze the proportion of sexual activity episodes linked to hypoglycemia and compare frequency and mean glucose levels on days with and without sexual activity. Participants data are anonymized and securely handled. The study hopes to help reduce patient fears and guide future recommendations for safe sexual activity with insulin therapy.

"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"